nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP2D6—Fingolimod—multiple sclerosis	0.0898	0.11	CbGbCtD
Domperidone—ABCB1—Methylprednisolone—multiple sclerosis	0.0614	0.075	CbGbCtD
Domperidone—CYP3A4—Fingolimod—multiple sclerosis	0.0571	0.0697	CbGbCtD
Domperidone—CYP3A7—Dexamethasone—multiple sclerosis	0.0476	0.0581	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0476	0.0581	CbGbCtD
Domperidone—CYP2B6—Dexamethasone—multiple sclerosis	0.0453	0.0553	CbGbCtD
Domperidone—ABCB1—Mitoxantrone—multiple sclerosis	0.0448	0.0547	CbGbCtD
Domperidone—ABCB1—Betamethasone—multiple sclerosis	0.0399	0.0487	CbGbCtD
Domperidone—ABCB1—Prednisolone—multiple sclerosis	0.0394	0.0481	CbGbCtD
Domperidone—ABCB1—Prednisone—multiple sclerosis	0.0372	0.0454	CbGbCtD
Domperidone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0368	0.0449	CbGbCtD
Domperidone—CYP3A5—Dexamethasone—multiple sclerosis	0.0357	0.0436	CbGbCtD
Domperidone—CYP2C8—Dexamethasone—multiple sclerosis	0.0343	0.0419	CbGbCtD
Domperidone—CYP3A4—Triamcinolone—multiple sclerosis	0.0279	0.034	CbGbCtD
Domperidone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0268	0.0328	CbGbCtD
Domperidone—CYP3A4—Betamethasone—multiple sclerosis	0.0239	0.0292	CbGbCtD
Domperidone—CYP3A4—Prednisolone—multiple sclerosis	0.0236	0.0288	CbGbCtD
Domperidone—ABCB1—Dexamethasone—multiple sclerosis	0.0232	0.0284	CbGbCtD
Domperidone—CYP3A4—Prednisone—multiple sclerosis	0.0223	0.0272	CbGbCtD
Domperidone—CYP2D6—Dexamethasone—multiple sclerosis	0.0219	0.0267	CbGbCtD
Domperidone—ABCB1—Methotrexate—multiple sclerosis	0.0187	0.0228	CbGbCtD
Domperidone—CYP3A4—Dexamethasone—multiple sclerosis	0.0139	0.017	CbGbCtD
Domperidone—Sudden death—Mitoxantrone—multiple sclerosis	0.00297	0.0304	CcSEcCtD
Domperidone—Migraine—Fingolimod—multiple sclerosis	0.00291	0.0298	CcSEcCtD
Domperidone—Menstruation irregular—Prednisolone—multiple sclerosis	0.00225	0.023	CcSEcCtD
Domperidone—Menstruation irregular—Triamcinolone—multiple sclerosis	0.00207	0.0212	CcSEcCtD
Domperidone—Menstruation irregular—Methylprednisolone—multiple sclerosis	0.00207	0.0211	CcSEcCtD
Domperidone—Menstruation irregular—Betamethasone—multiple sclerosis	0.00188	0.0192	CcSEcCtD
Domperidone—Menstruation irregular—Dexamethasone—multiple sclerosis	0.00188	0.0192	CcSEcCtD
Domperidone—Disorientation—Cladribine—multiple sclerosis	0.00188	0.0192	CcSEcCtD
Domperidone—Lethargy—Cladribine—multiple sclerosis	0.00171	0.0175	CcSEcCtD
Domperidone—Menstruation irregular—Prednisone—multiple sclerosis	0.00164	0.0167	CcSEcCtD
Domperidone—Palpitations—Fingolimod—multiple sclerosis	0.00158	0.0161	CcSEcCtD
Domperidone—Sudden death—Methotrexate—multiple sclerosis	0.00148	0.0151	CcSEcCtD
Domperidone—Hypotension—Fingolimod—multiple sclerosis	0.00136	0.0139	CcSEcCtD
Domperidone—Conjunctivitis—Cladribine—multiple sclerosis	0.00126	0.0128	CcSEcCtD
Domperidone—Asthenia—Fingolimod—multiple sclerosis	0.00104	0.0107	CcSEcCtD
Domperidone—Arrhythmia—Cladribine—multiple sclerosis	0.00104	0.0106	CcSEcCtD
Domperidone—Pruritus—Fingolimod—multiple sclerosis	0.00103	0.0105	CcSEcCtD
Domperidone—Diarrhoea—Fingolimod—multiple sclerosis	0.000995	0.0102	CcSEcCtD
Domperidone—Dizziness—Fingolimod—multiple sclerosis	0.000962	0.00983	CcSEcCtD
Domperidone—Headache—Fingolimod—multiple sclerosis	0.000911	0.00932	CcSEcCtD
Domperidone—Drowsiness—Mitoxantrone—multiple sclerosis	0.00085	0.00869	CcSEcCtD
Domperidone—Arrhythmia—Azathioprine—multiple sclerosis	0.000843	0.00862	CcSEcCtD
Domperidone—Stomatitis—Mitoxantrone—multiple sclerosis	0.000828	0.00847	CcSEcCtD
Domperidone—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.000826	0.00845	CcSEcCtD
Domperidone—Oedema—Cladribine—multiple sclerosis	0.000825	0.00843	CcSEcCtD
Domperidone—Irritability—Methylprednisolone—multiple sclerosis	0.000792	0.0081	CcSEcCtD
Domperidone—Hypotension—Cladribine—multiple sclerosis	0.000771	0.00788	CcSEcCtD
Domperidone—Lethargy—Dexamethasone—multiple sclerosis	0.00077	0.00788	CcSEcCtD
Domperidone—Lethargy—Betamethasone—multiple sclerosis	0.00077	0.00788	CcSEcCtD
Domperidone—Insomnia—Cladribine—multiple sclerosis	0.000746	0.00762	CcSEcCtD
Domperidone—Migraine—Betamethasone—multiple sclerosis	0.000743	0.0076	CcSEcCtD
Domperidone—Migraine—Dexamethasone—multiple sclerosis	0.000743	0.0076	CcSEcCtD
Domperidone—Somnolence—Cladribine—multiple sclerosis	0.000733	0.00749	CcSEcCtD
Domperidone—Irritability—Betamethasone—multiple sclerosis	0.000721	0.00737	CcSEcCtD
Domperidone—Irritability—Dexamethasone—multiple sclerosis	0.000721	0.00737	CcSEcCtD
Domperidone—Constipation—Cladribine—multiple sclerosis	0.000705	0.00721	CcSEcCtD
Domperidone—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000682	0.00697	CcSEcCtD
Domperidone—Conjunctivitis—Prednisolone—multiple sclerosis	0.000678	0.00693	CcSEcCtD
Domperidone—Gynaecomastia—Methotrexate—multiple sclerosis	0.000677	0.00692	CcSEcCtD
Domperidone—Lethargy—Prednisone—multiple sclerosis	0.000671	0.00686	CcSEcCtD
Domperidone—Urticaria—Cladribine—multiple sclerosis	0.000655	0.0067	CcSEcCtD
Domperidone—Abdominal pain—Cladribine—multiple sclerosis	0.000652	0.00666	CcSEcCtD
Domperidone—Irritability—Prednisone—multiple sclerosis	0.000628	0.00642	CcSEcCtD
Domperidone—Hypotension—Azathioprine—multiple sclerosis	0.000627	0.0064	CcSEcCtD
Domperidone—Conjunctivitis—Triamcinolone—multiple sclerosis	0.000623	0.00637	CcSEcCtD
Domperidone—Asthenia—Cladribine—multiple sclerosis	0.000592	0.00605	CcSEcCtD
Domperidone—Pruritus—Cladribine—multiple sclerosis	0.000583	0.00596	CcSEcCtD
Domperidone—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000566	0.00578	CcSEcCtD
Domperidone—Conjunctivitis—Betamethasone—multiple sclerosis	0.000566	0.00578	CcSEcCtD
Domperidone—Diarrhoea—Cladribine—multiple sclerosis	0.000564	0.00577	CcSEcCtD
Domperidone—Lethargy—Methotrexate—multiple sclerosis	0.000561	0.00573	CcSEcCtD
Domperidone—Arrhythmia—Prednisolone—multiple sclerosis	0.000559	0.00572	CcSEcCtD
Domperidone—Dizziness—Cladribine—multiple sclerosis	0.000545	0.00557	CcSEcCtD
Domperidone—Oedema—Mitoxantrone—multiple sclerosis	0.000542	0.00554	CcSEcCtD
Domperidone—Abdominal pain—Azathioprine—multiple sclerosis	0.00053	0.00542	CcSEcCtD
Domperidone—Irritability—Methotrexate—multiple sclerosis	0.000524	0.00536	CcSEcCtD
Domperidone—Vomiting—Cladribine—multiple sclerosis	0.000524	0.00536	CcSEcCtD
Domperidone—Rash—Cladribine—multiple sclerosis	0.00052	0.00532	CcSEcCtD
Domperidone—Dermatitis—Cladribine—multiple sclerosis	0.00052	0.00531	CcSEcCtD
Domperidone—Headache—Cladribine—multiple sclerosis	0.000517	0.00528	CcSEcCtD
Domperidone—Arrhythmia—Triamcinolone—multiple sclerosis	0.000514	0.00526	CcSEcCtD
Domperidone—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000513	0.00524	CcSEcCtD
Domperidone—Hypotension—Mitoxantrone—multiple sclerosis	0.000507	0.00518	CcSEcCtD
Domperidone—Nausea—Cladribine—multiple sclerosis	0.00049	0.00501	CcSEcCtD
Domperidone—Somnolence—Mitoxantrone—multiple sclerosis	0.000482	0.00493	CcSEcCtD
Domperidone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000477	0.00488	CcSEcCtD
Domperidone—Arrhythmia—Dexamethasone—multiple sclerosis	0.000467	0.00477	CcSEcCtD
Domperidone—Arrhythmia—Betamethasone—multiple sclerosis	0.000467	0.00477	CcSEcCtD
Domperidone—Constipation—Mitoxantrone—multiple sclerosis	0.000464	0.00474	CcSEcCtD
Domperidone—Diarrhoea—Azathioprine—multiple sclerosis	0.000459	0.00469	CcSEcCtD
Domperidone—Oedema—Prednisolone—multiple sclerosis	0.000445	0.00455	CcSEcCtD
Domperidone—Dysuria—Methotrexate—multiple sclerosis	0.000444	0.00454	CcSEcCtD
Domperidone—Dizziness—Azathioprine—multiple sclerosis	0.000443	0.00453	CcSEcCtD
Domperidone—Urticaria—Mitoxantrone—multiple sclerosis	0.000431	0.0044	CcSEcCtD
Domperidone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000429	0.00438	CcSEcCtD
Domperidone—Vomiting—Azathioprine—multiple sclerosis	0.000426	0.00436	CcSEcCtD
Domperidone—Drowsiness—Methotrexate—multiple sclerosis	0.000423	0.00433	CcSEcCtD
Domperidone—Rash—Azathioprine—multiple sclerosis	0.000423	0.00432	CcSEcCtD
Domperidone—Dermatitis—Azathioprine—multiple sclerosis	0.000422	0.00432	CcSEcCtD
Domperidone—Headache—Azathioprine—multiple sclerosis	0.00042	0.00429	CcSEcCtD
Domperidone—Dry mouth—Triamcinolone—multiple sclerosis	0.000417	0.00426	CcSEcCtD
Domperidone—Stomatitis—Methotrexate—multiple sclerosis	0.000413	0.00422	CcSEcCtD
Domperidone—Conjunctivitis—Methotrexate—multiple sclerosis	0.000412	0.00421	CcSEcCtD
Domperidone—Oedema—Triamcinolone—multiple sclerosis	0.000409	0.00418	CcSEcCtD
Domperidone—Arrhythmia—Prednisone—multiple sclerosis	0.000406	0.00415	CcSEcCtD
Domperidone—Insomnia—Prednisolone—multiple sclerosis	0.000402	0.00411	CcSEcCtD
Domperidone—Nausea—Azathioprine—multiple sclerosis	0.000398	0.00407	CcSEcCtD
Domperidone—Asthenia—Mitoxantrone—multiple sclerosis	0.000389	0.00398	CcSEcCtD
Domperidone—Hypotension—Methylprednisolone—multiple sclerosis	0.000381	0.0039	CcSEcCtD
Domperidone—Oedema—Betamethasone—multiple sclerosis	0.000371	0.00379	CcSEcCtD
Domperidone—Oedema—Dexamethasone—multiple sclerosis	0.000371	0.00379	CcSEcCtD
Domperidone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000371	0.00379	CcSEcCtD
Domperidone—Insomnia—Triamcinolone—multiple sclerosis	0.00037	0.00378	CcSEcCtD
Domperidone—Insomnia—Methylprednisolone—multiple sclerosis	0.000369	0.00377	CcSEcCtD
Domperidone—Dyspepsia—Triamcinolone—multiple sclerosis	0.00036	0.00368	CcSEcCtD
Domperidone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000359	0.00367	CcSEcCtD
Domperidone—Urticaria—Prednisolone—multiple sclerosis	0.000353	0.00361	CcSEcCtD
Domperidone—Hypotension—Dexamethasone—multiple sclerosis	0.000347	0.00354	CcSEcCtD
Domperidone—Hypotension—Betamethasone—multiple sclerosis	0.000347	0.00354	CcSEcCtD
Domperidone—Vomiting—Mitoxantrone—multiple sclerosis	0.000345	0.00352	CcSEcCtD
Domperidone—Rash—Mitoxantrone—multiple sclerosis	0.000342	0.00349	CcSEcCtD
Domperidone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000341	0.00349	CcSEcCtD
Domperidone—Headache—Mitoxantrone—multiple sclerosis	0.00034	0.00347	CcSEcCtD
Domperidone—Insomnia—Dexamethasone—multiple sclerosis	0.000336	0.00343	CcSEcCtD
Domperidone—Insomnia—Betamethasone—multiple sclerosis	0.000336	0.00343	CcSEcCtD
Domperidone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000327	0.00334	CcSEcCtD
Domperidone—Dyspepsia—Betamethasone—multiple sclerosis	0.000327	0.00334	CcSEcCtD
Domperidone—Urticaria—Triamcinolone—multiple sclerosis	0.000325	0.00332	CcSEcCtD
Domperidone—Urticaria—Methylprednisolone—multiple sclerosis	0.000324	0.00331	CcSEcCtD
Domperidone—Oedema—Prednisone—multiple sclerosis	0.000323	0.0033	CcSEcCtD
Domperidone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000323	0.0033	CcSEcCtD
Domperidone—Nausea—Mitoxantrone—multiple sclerosis	0.000322	0.00329	CcSEcCtD
Domperidone—Urticaria—Dexamethasone—multiple sclerosis	0.000295	0.00301	CcSEcCtD
Domperidone—Urticaria—Betamethasone—multiple sclerosis	0.000295	0.00301	CcSEcCtD
Domperidone—Dizziness—Prednisolone—multiple sclerosis	0.000294	0.00301	CcSEcCtD
Domperidone—Asthenia—Triamcinolone—multiple sclerosis	0.000293	0.003	CcSEcCtD
Domperidone—Abdominal pain—Betamethasone—multiple sclerosis	0.000293	0.003	CcSEcCtD
Domperidone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000293	0.003	CcSEcCtD
Domperidone—Asthenia—Methylprednisolone—multiple sclerosis	0.000293	0.00299	CcSEcCtD
Domperidone—Insomnia—Prednisone—multiple sclerosis	0.000292	0.00299	CcSEcCtD
Domperidone—Pruritus—Triamcinolone—multiple sclerosis	0.000289	0.00296	CcSEcCtD
Domperidone—Pruritus—Methylprednisolone—multiple sclerosis	0.000289	0.00295	CcSEcCtD
Domperidone—Dyspepsia—Prednisone—multiple sclerosis	0.000284	0.00291	CcSEcCtD
Domperidone—Rash—Prednisolone—multiple sclerosis	0.00028	0.00287	CcSEcCtD
Domperidone—Dermatitis—Prednisolone—multiple sclerosis	0.00028	0.00286	CcSEcCtD
Domperidone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000279	0.00285	CcSEcCtD
Domperidone—Headache—Prednisolone—multiple sclerosis	0.000279	0.00285	CcSEcCtD
Domperidone—Constipation—Prednisone—multiple sclerosis	0.000276	0.00282	CcSEcCtD
Domperidone—Dizziness—Triamcinolone—multiple sclerosis	0.00027	0.00276	CcSEcCtD
Domperidone—Dizziness—Methylprednisolone—multiple sclerosis	0.00027	0.00276	CcSEcCtD
Domperidone—Asthenia—Betamethasone—multiple sclerosis	0.000266	0.00272	CcSEcCtD
Domperidone—Asthenia—Dexamethasone—multiple sclerosis	0.000266	0.00272	CcSEcCtD
Domperidone—Nausea—Prednisolone—multiple sclerosis	0.000264	0.0027	CcSEcCtD
Domperidone—Pruritus—Betamethasone—multiple sclerosis	0.000263	0.00268	CcSEcCtD
Domperidone—Pruritus—Dexamethasone—multiple sclerosis	0.000263	0.00268	CcSEcCtD
Domperidone—Vomiting—Triamcinolone—multiple sclerosis	0.00026	0.00266	CcSEcCtD
Domperidone—Vomiting—Methylprednisolone—multiple sclerosis	0.000259	0.00265	CcSEcCtD
Domperidone—Rash—Triamcinolone—multiple sclerosis	0.000258	0.00264	CcSEcCtD
Domperidone—Dermatitis—Triamcinolone—multiple sclerosis	0.000258	0.00263	CcSEcCtD
Domperidone—Rash—Methylprednisolone—multiple sclerosis	0.000257	0.00263	CcSEcCtD
Domperidone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000257	0.00263	CcSEcCtD
Domperidone—Urticaria—Prednisone—multiple sclerosis	0.000257	0.00262	CcSEcCtD
Domperidone—Headache—Triamcinolone—multiple sclerosis	0.000256	0.00262	CcSEcCtD
Domperidone—Headache—Methylprednisolone—multiple sclerosis	0.000256	0.00261	CcSEcCtD
Domperidone—Abdominal pain—Prednisone—multiple sclerosis	0.000255	0.00261	CcSEcCtD
Domperidone—Diarrhoea—Betamethasone—multiple sclerosis	0.000254	0.0026	CcSEcCtD
Domperidone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000254	0.0026	CcSEcCtD
Domperidone—Hypotension—Methotrexate—multiple sclerosis	0.000252	0.00258	CcSEcCtD
Domperidone—Dizziness—Betamethasone—multiple sclerosis	0.000245	0.00251	CcSEcCtD
Domperidone—Dizziness—Dexamethasone—multiple sclerosis	0.000245	0.00251	CcSEcCtD
Domperidone—Insomnia—Methotrexate—multiple sclerosis	0.000244	0.0025	CcSEcCtD
Domperidone—Nausea—Triamcinolone—multiple sclerosis	0.000243	0.00248	CcSEcCtD
Domperidone—Nausea—Methylprednisolone—multiple sclerosis	0.000242	0.00248	CcSEcCtD
Domperidone—Somnolence—Methotrexate—multiple sclerosis	0.00024	0.00245	CcSEcCtD
Domperidone—Dyspepsia—Methotrexate—multiple sclerosis	0.000238	0.00243	CcSEcCtD
Domperidone—Vomiting—Dexamethasone—multiple sclerosis	0.000236	0.00241	CcSEcCtD
Domperidone—Vomiting—Betamethasone—multiple sclerosis	0.000236	0.00241	CcSEcCtD
Domperidone—Rash—Betamethasone—multiple sclerosis	0.000234	0.00239	CcSEcCtD
Domperidone—Rash—Dexamethasone—multiple sclerosis	0.000234	0.00239	CcSEcCtD
Domperidone—Dermatitis—Dexamethasone—multiple sclerosis	0.000234	0.00239	CcSEcCtD
Domperidone—Dermatitis—Betamethasone—multiple sclerosis	0.000234	0.00239	CcSEcCtD
Domperidone—Headache—Betamethasone—multiple sclerosis	0.000232	0.00238	CcSEcCtD
Domperidone—Headache—Dexamethasone—multiple sclerosis	0.000232	0.00238	CcSEcCtD
Domperidone—Asthenia—Prednisone—multiple sclerosis	0.000232	0.00237	CcSEcCtD
Domperidone—Pruritus—Prednisone—multiple sclerosis	0.000229	0.00234	CcSEcCtD
Domperidone—Diarrhoea—Prednisone—multiple sclerosis	0.000221	0.00226	CcSEcCtD
Domperidone—Nausea—Dexamethasone—multiple sclerosis	0.00022	0.00225	CcSEcCtD
Domperidone—Nausea—Betamethasone—multiple sclerosis	0.00022	0.00225	CcSEcCtD
Domperidone—Urticaria—Methotrexate—multiple sclerosis	0.000215	0.00219	CcSEcCtD
Domperidone—Dizziness—Prednisone—multiple sclerosis	0.000214	0.00218	CcSEcCtD
Domperidone—Abdominal pain—Methotrexate—multiple sclerosis	0.000214	0.00218	CcSEcCtD
Domperidone—Vomiting—Prednisone—multiple sclerosis	0.000205	0.0021	CcSEcCtD
Domperidone—Rash—Prednisone—multiple sclerosis	0.000204	0.00208	CcSEcCtD
Domperidone—Dermatitis—Prednisone—multiple sclerosis	0.000204	0.00208	CcSEcCtD
Domperidone—Headache—Prednisone—multiple sclerosis	0.000202	0.00207	CcSEcCtD
Domperidone—Asthenia—Methotrexate—multiple sclerosis	0.000194	0.00198	CcSEcCtD
Domperidone—Nausea—Prednisone—multiple sclerosis	0.000192	0.00196	CcSEcCtD
Domperidone—Pruritus—Methotrexate—multiple sclerosis	0.000191	0.00195	CcSEcCtD
Domperidone—Diarrhoea—Methotrexate—multiple sclerosis	0.000185	0.00189	CcSEcCtD
Domperidone—Dizziness—Methotrexate—multiple sclerosis	0.000179	0.00183	CcSEcCtD
Domperidone—Vomiting—Methotrexate—multiple sclerosis	0.000172	0.00176	CcSEcCtD
Domperidone—Rash—Methotrexate—multiple sclerosis	0.00017	0.00174	CcSEcCtD
Domperidone—Dermatitis—Methotrexate—multiple sclerosis	0.00017	0.00174	CcSEcCtD
Domperidone—Headache—Methotrexate—multiple sclerosis	0.000169	0.00173	CcSEcCtD
Domperidone—Nausea—Methotrexate—multiple sclerosis	0.00016	0.00164	CcSEcCtD
Domperidone—DRD2—GPCR downstream signaling—GPR65—multiple sclerosis	7.56e-05	0.000909	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TAGAP—multiple sclerosis	7.52e-05	0.000905	CbGpPWpGaD
Domperidone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.46e-05	0.000897	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SRM—multiple sclerosis	7.45e-05	0.000896	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	7.41e-05	0.000891	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—CCL5—multiple sclerosis	7.37e-05	0.000886	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CNR1—multiple sclerosis	7.28e-05	0.000875	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	7.26e-05	0.000873	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	7.26e-05	0.000873	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—RGS1—multiple sclerosis	7.24e-05	0.000871	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.21e-05	0.000867	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.18e-05	0.000864	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.18e-05	0.000863	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.1e-05	0.000854	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.1e-05	0.000854	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.1e-05	0.000854	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—POMC—multiple sclerosis	7.07e-05	0.00085	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CCR1—multiple sclerosis	6.92e-05	0.000832	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL13—multiple sclerosis	6.92e-05	0.000832	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.91e-05	0.000831	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.91e-05	0.000831	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.9e-05	0.000829	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.89e-05	0.000829	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GPR65—multiple sclerosis	6.87e-05	0.000826	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.82e-05	0.00082	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.76e-05	0.000813	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.67e-05	0.000802	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.67e-05	0.000802	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GPC5—multiple sclerosis	6.64e-05	0.000799	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—CCR5—multiple sclerosis	6.64e-05	0.000799	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LINGO1—multiple sclerosis	6.64e-05	0.000798	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—S1PR1—multiple sclerosis	6.58e-05	0.000791	CbGpPWpGaD
Domperidone—DRD2—G alpha (i) signalling events—POMC—multiple sclerosis	6.56e-05	0.000789	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CXCL10—multiple sclerosis	6.55e-05	0.000788	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SRM—multiple sclerosis	6.46e-05	0.000776	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.43e-05	0.000774	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.43e-05	0.000774	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GPC5—multiple sclerosis	6.4e-05	0.000769	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL13—multiple sclerosis	6.28e-05	0.000755	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCR1—multiple sclerosis	6.28e-05	0.000755	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PTGER4—multiple sclerosis	6.2e-05	0.000745	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.08e-05	0.000731	CbGpPWpGaD
Domperidone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.05e-05	0.000727	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CXCR3—multiple sclerosis	5.99e-05	0.00072	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.98e-05	0.000719	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—MAPK1—multiple sclerosis	5.87e-05	0.000706	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CCL3—multiple sclerosis	5.85e-05	0.000703	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CCR2—multiple sclerosis	5.82e-05	0.0007	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TAGAP—multiple sclerosis	5.76e-05	0.000692	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CCL5—multiple sclerosis	5.64e-05	0.000678	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PTGER4—multiple sclerosis	5.63e-05	0.000677	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SRM—multiple sclerosis	5.62e-05	0.000676	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.6e-05	0.000673	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RGS1—multiple sclerosis	5.59e-05	0.000672	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—RRM1—multiple sclerosis	5.51e-05	0.000662	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.45e-05	0.000655	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCR3—multiple sclerosis	5.44e-05	0.000654	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CNR1—multiple sclerosis	5.37e-05	0.000646	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.37e-05	0.000646	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.37e-05	0.000646	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GPR65—multiple sclerosis	5.3e-05	0.000637	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SRM—multiple sclerosis	5.3e-05	0.000637	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CCR2—multiple sclerosis	5.29e-05	0.000636	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	5.25e-05	0.000631	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	5.25e-05	0.000631	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.23e-05	0.000629	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.22e-05	0.000627	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—POMC—multiple sclerosis	5.19e-05	0.000624	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.1e-05	0.000614	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CCR5—multiple sclerosis	5.08e-05	0.000611	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—CCL2—multiple sclerosis	5.08e-05	0.000611	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	5.03e-05	0.000605	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.91e-05	0.000591	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.91e-05	0.000591	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GPC5—multiple sclerosis	4.9e-05	0.000589	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CNR1—multiple sclerosis	4.88e-05	0.000587	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL13—multiple sclerosis	4.85e-05	0.000583	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCR1—multiple sclerosis	4.85e-05	0.000583	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CXCL10—multiple sclerosis	4.84e-05	0.000582	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.82e-05	0.000579	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.8e-05	0.000577	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.74e-05	0.00057	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.58e-05	0.000551	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.55e-05	0.000547	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.55e-05	0.000547	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SRM—multiple sclerosis	4.49e-05	0.00054	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	4.47e-05	0.000538	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	4.46e-05	0.000536	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.45e-05	0.000535	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCL10—multiple sclerosis	4.39e-05	0.000528	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	4.31e-05	0.000518	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RGS1—multiple sclerosis	4.28e-05	0.000515	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—IL6—multiple sclerosis	4.22e-05	0.000508	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CCL5—multiple sclerosis	4.17e-05	0.000501	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.16e-05	0.0005	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	4.16e-05	0.0005	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.16e-05	0.0005	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	4.11e-05	0.000495	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.07e-05	0.00049	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GPR65—multiple sclerosis	4.06e-05	0.000488	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	4.05e-05	0.000487	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.98e-05	0.000479	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—POMC—multiple sclerosis	3.97e-05	0.000478	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.96e-05	0.000476	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.96e-05	0.000476	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	3.89e-05	0.000467	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CCL5—multiple sclerosis	3.78e-05	0.000455	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CCR5—multiple sclerosis	3.75e-05	0.000451	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	3.73e-05	0.000449	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.73e-05	0.000449	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.73e-05	0.000449	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCR1—multiple sclerosis	3.71e-05	0.000446	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	3.71e-05	0.000446	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.7e-05	0.000445	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.7e-05	0.000445	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GPC5—multiple sclerosis	3.62e-05	0.000436	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.46e-05	0.000417	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL3—multiple sclerosis	3.45e-05	0.000415	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.45e-05	0.000414	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.41e-05	0.000411	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CCR5—multiple sclerosis	3.41e-05	0.00041	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	3.36e-05	0.000404	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2RA—multiple sclerosis	3.36e-05	0.000404	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTGER4—multiple sclerosis	3.33e-05	0.0004	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PGR—multiple sclerosis	3.27e-05	0.000394	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	3.23e-05	0.000388	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCR3—multiple sclerosis	3.21e-05	0.000386	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.21e-05	0.000386	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	3.19e-05	0.000383	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CD28—multiple sclerosis	3.18e-05	0.000383	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.16e-05	0.00038	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.16e-05	0.00038	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—BCHE—multiple sclerosis	3.16e-05	0.00038	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCR2—multiple sclerosis	3.12e-05	0.000376	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.09e-05	0.000372	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—RRM1—multiple sclerosis	3e-05	0.000361	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—POMC—multiple sclerosis	2.93e-05	0.000353	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	2.89e-05	0.000348	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.89e-05	0.000348	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CNR1—multiple sclerosis	2.88e-05	0.000347	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	2.87e-05	0.000345	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.83e-05	0.00034	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.83e-05	0.00034	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.77e-05	0.000333	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.76e-05	0.000332	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.71e-05	0.000326	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.67e-05	0.000322	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—POMC—multiple sclerosis	2.66e-05	0.00032	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL3—multiple sclerosis	2.64e-05	0.000318	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	2.61e-05	0.000314	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CCL2—multiple sclerosis	2.61e-05	0.000313	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL10—multiple sclerosis	2.6e-05	0.000312	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.58e-05	0.00031	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	2.57e-05	0.000309	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	2.54e-05	0.000306	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PGR—multiple sclerosis	2.51e-05	0.000301	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	2.46e-05	0.000296	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.44e-05	0.000294	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.44e-05	0.000294	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD28—multiple sclerosis	2.43e-05	0.000293	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.4e-05	0.000288	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCR2—multiple sclerosis	2.39e-05	0.000287	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—TYK2—multiple sclerosis	2.37e-05	0.000285	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.34e-05	0.000281	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.3e-05	0.000276	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.29e-05	0.000275	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CD86—multiple sclerosis	2.27e-05	0.000273	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	2.24e-05	0.00027	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL5—multiple sclerosis	2.23e-05	0.000269	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.23e-05	0.000268	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CNR1—multiple sclerosis	2.21e-05	0.000265	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—multiple sclerosis	2.17e-05	0.000261	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.09e-05	0.000252	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SPP1—multiple sclerosis	2.07e-05	0.000249	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—POMC—multiple sclerosis	2.04e-05	0.000245	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCR5—multiple sclerosis	2.01e-05	0.000242	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.99e-05	0.00024	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.99e-05	0.000239	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2RA—multiple sclerosis	1.98e-05	0.000239	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.98e-05	0.000238	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—multiple sclerosis	1.97e-05	0.000237	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—APOE—multiple sclerosis	1.9e-05	0.000229	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.86e-05	0.000224	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.85e-05	0.000222	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APOE—multiple sclerosis	1.83e-05	0.00022	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.81e-05	0.000218	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.74e-05	0.000209	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.73e-05	0.000209	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000207	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.71e-05	0.000206	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.66e-05	0.0002	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CD80—multiple sclerosis	1.66e-05	0.000199	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.63e-05	0.000196	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000195	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.6e-05	0.000192	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.58e-05	0.00019	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—POMC—multiple sclerosis	1.57e-05	0.000189	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.54e-05	0.000185	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL2—multiple sclerosis	1.54e-05	0.000185	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.52e-05	0.000183	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.51e-05	0.000181	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.51e-05	0.000181	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.49e-05	0.000179	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.46e-05	0.000175	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOE—multiple sclerosis	1.41e-05	0.000169	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.4e-05	0.000169	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.4e-05	0.000168	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000166	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000165	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	0.000152	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000145	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	0.000145	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOE—multiple sclerosis	1.19e-05	0.000143	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—POMC—multiple sclerosis	1.18e-05	0.000142	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	0.000142	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.16e-05	0.00014	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.16e-05	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	0.000139	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000132	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.1e-05	0.000132	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—multiple sclerosis	1.08e-05	0.000129	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	0.000129	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000128	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000125	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—POMC—multiple sclerosis	1.02e-05	0.000123	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—multiple sclerosis	9.79e-06	0.000118	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOE—multiple sclerosis	9.78e-06	0.000118	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—multiple sclerosis	9.33e-06	0.000112	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—multiple sclerosis	9.1e-06	0.000109	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	9.07e-06	0.000109	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—POMC—multiple sclerosis	8.91e-06	0.000107	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—multiple sclerosis	8.9e-06	0.000107	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	8.9e-06	0.000107	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—multiple sclerosis	8.86e-06	0.000106	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.42e-06	0.000101	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—POMC—multiple sclerosis	8.4e-06	0.000101	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOE—multiple sclerosis	8.28e-06	9.96e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—multiple sclerosis	8.13e-06	9.77e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—multiple sclerosis	7.66e-06	9.21e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.49e-06	9.01e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—POMC—multiple sclerosis	7.12e-06	8.56e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.96e-06	8.37e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.94e-06	8.35e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—multiple sclerosis	6.84e-06	8.22e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	6.81e-06	8.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—multiple sclerosis	6.49e-06	7.8e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOE—multiple sclerosis	6.39e-06	7.69e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—POMC—multiple sclerosis	5.49e-06	6.6e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.23e-06	6.29e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—multiple sclerosis	5.01e-06	6.02e-05	CbGpPWpGaD
